Mitochondrial disorders

Handbook of the Cerebellum and Cerebellar Disorders

Volumn , Issue , 2013, Pages 2269-2312

  Di Donato, Stefano ^a   Marmolino, Daniele ^b   Taroni, Franco ^a,c  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c Unit of Genetics of Neurodegenerative and Metabolic Diseases Istituto Neurologico Carlo Besta   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84957873679     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-1333-8_102     Document Type: Chapter

References (215)

1. Abu-Amero K, Al-Dhalaan H, Bohlega S et al (2009) A patient with typical clinical features of mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) but without an obvious genetic cause: a case report. J Med Case Rep 3:77
2. Allikmets R, Raskind WH, Hutchinson A et al (1999) Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and Ataxia (XLSA/A). Hum Mol Genet 8:743-749
3. Alper G, Narayanan V (2003) Friedreich’s Ataxia. Pediatr Neurol 28:335-341
4. Ankel-Simons F, Cummins J (1996) Misconceptions about mitochondria and mammalian fertilization: implications for theories on human evolution. Proc Natl Acad Sci USA 93:13859-63
5. Babcock M, de Silva D, Oaks R et al (1997) Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 276:1709
6. Baughman J, Mootha V (2006) Buffering mitochondrial DNA variation. Nat Genet 38:1232-1233
7. Bekri S, Kispal G, Lange H et al (2000) Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with Ataxia with disruption of cytosolic iron-sulfur protein maturation. Blood 96:3256-3264
8. Belevich I, Verkohovsky M, Wilstrom M (2006) Proton-coupled electron transfer drives the proton pump of cytochrome c oxidase. Nature 440:829-832
9. Berenberg R, Pellock J, Di Mauro S et al (1977) Lumping or splitting? “Ophthalmoplegia-plus” or Kearns-Sayre syndrome? Ann Neurol 1:37-54
10. Berkovic SF, Cochius J, Andermann E et al (1993) Progressive myoclonus epilepsies: clinical and genetic aspects. Epilepsia 3:19-30
11. Bhidayasiri R, Perlman SL, Pulst SM et al (2005) Late-onset Friedreich Ataxia: phenotypic analysis, magnetic resonance imaging findings, and review of the literature. Arch Neurol 62:1865-1869
12. Bidichandani SI, Ashizawa T, Patel PI (1997) Atypical Friedreich’s Ataxia caused by compound heterozygosity for a novel missense mutation and the GAA triplet-repeat expansion. Am J Hum Genet 60:1251-1256
13. Bidichandani SI, Ashizawa T, Patel PI (1998) The GAA triplet-repeat expansion in Friedreich Ataxia interferes with transcription and may be associated with an unusual DNA structure. Am J Hum Genet 62:111-121
14. Bidichandani SI, Garcia CA, Patel PI et al (2000) Very late-onset Friedreich Ataxia despite large GAA triplet repeat expansions. Arch Neurol 57:246-251
15. Blok R, Thorburn D, Thompson G et al (1995) A topoisomerase II cleavage site is associated with a novel mitochondrial DNA deletion. Hum Genet 95:75-81
16. Boddaert N, Le Quan Sang KH, Rotig A et al (2007) Selective iron chelation in Friedreich Ataxia: biologic and clinical implications. Blood 110:401-408
17. Boesch S, Sturm B, Hering S et al (2008) Neurological effects of recombinant human erythropoietin in Friedreich’s Ataxia: a clinical pilot trial. Mov Disord 23:1940-1944
18. Bomer G, Zeviani M, Tiranti V et al (2000) Decreased aminoacylation of mutant tRNAs in MELAS but not in MERRF patients. Hum Mol Genet 9:467-475
19. Cagnoli C, Stevanin G, Brussino A et al (2010) Missense mutations in the AFG3L2 proteolytic domain account for approximately 1.5% of European autosomal dominant cerebellar Ataxias. Hum Mutat 31:1117-1124
20. Campos Y, Martin M, Rubio J et al (1997) Leigh syndrome associated with the T9176C mutation in the ATPase6 gene of mitochondrial DNA. Neurology 49:595-597
21. Campuzano V, Montermini L, Molto MD et al (1996) Friedreich’s Ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271:1423-1427
22. Campuzano V, Montermini L, Lutz Y et al (1997) Frataxin is reduced in Friedreich Ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 6:1771-1780
23. Carelli V, Giordano C, d’Amati G (2003) Pathogenic expression of homoplasmic mtDNA mutations needs a complex nuclear-mitochondrial interaction. Trends Genet 19:257-262
24. Casali C, Fabrizi GM, Santorelli FM et al (1999) Mitochondrial G8363A mutation presenting as cerebellar Ataxia and lipomas in an Italian family. Neurology 52:1103-1104
25. Casari G, De Fusco M, Ciarmatori S et al (1998) Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93:973-983
26. Casazza F, Morpurgo M (1996) The varying evolution of Friedreich’s Ataxia cardiomyopathy. Am J Cardiol 77:895-898
27. Castagna A, Addis J, McInnes R et al (2007) Late onset Leigh syndrome and Ataxia due to a T to C mutation at bp 9,185 of mitochondrial DNA. Am J Med Genet 143:808-816
28. Cavadini P, Gellera C, Patel P et al (2000) Human frataxin maintains mitochondrial iron homeostasis in Saccharomyces cerevisiae. Hum Mol Genet 9:2523-2530
29. Chan D (2006) Mitochondria: dynamic organelles in disease, aging, and development. Cell 125:124152
30. Chan D (2007) Mitochondrial dynamics in disease. New Engl J Med 356:1707-709
31. Chantrel-Groussard K, Geromel V, Puccio H et al (2001) Disabled early recruitment of antioxidant defenses in Friedreich’s Ataxia. Hum Mol Genet 10:2061-2067
32. Chen H, McCaffery J, Chan D (2007) Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 130:548-562
33. Childs A, Hutchin T, Pysden K et al (2007) Variable phenotype including Leigh syndrome with a 9185 T > C mutation in the MTATP6 gene. Neuropediatrics 38:313-316
34. Chinnery P, Howell N, Lightowlers R et al (1997) Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain 120:1713-1721
35. Cho SJ, Lee MG, Yang JK et al (2000) Crystal structure of Escherichia coli CyaY protein reveals a previously unidentified fold for the evolutionarily conserved frataxin family. Proc Natl Acad Sci USA 97:8932-8937
36. Cohen BH, Chinnery PF, Copeland WC (2010) POLG-related disorders (Updated March 16, 2010). In: Pagon RA, Bird TD, Dolan CR, Stephens K (eds). GeneReviews at GeneTests: Medical Genetics Information Resource (database online). University of Washington, Seattle. 1993-2011. http://www.genetests.org
37. Corona P, Lamantea E, Greco M et al (2002) Novel heteroplasmic mtDNA mutation in a family with heterogeneous clinical presentations. Ann Neurol 51:118-122
38. Cossee M, Puccio H, Gansmuller A et al (2000) Inactivation of the Friedreich Ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum Mol Genet 9:1219-1226
39. Craig K, Ferrari G, Tiangyou W et al. (2007) The A467T and W748S POLG substitutions are a rare cause of adult-onset Ataxia in Europe. Brain 130: E69; author reply E70
40. de Brito O, Scorrano L (2008) Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456:605-610
41. De Michele G, Filla A, Cavalcanti F et al (1994) Late onset Friedreich’s disease: clinical features and mapping of mutation to the FRDA locus. J Neurol Neurosurg Psychiatry 57:977-979
42. De Vries D, van Engelen B, Gabreels F et al (1993) A second missense mutation in the mitochondrial ATPase 6 gene in Leigh’s syndrome. Ann Neurol 34:410-412
43. Debray F, Lambert M, Lortie A et al (2007) Longterm outcome of Leigh syndrome caused by the NARP-T8993C mtDNA mutation. Am J Med Genet 143:2046-2051
44. Delatycki MB, Williamson R, Forrest SM (2000) Friedreich Ataxia: an overview. J Med Genet 37:1-8
45. Deschauer M, Tennant S, Rokicka A et al (2007) MELAS associated with mutations in the POLG1 gene. Neurology 68:1741-1742
46. Desguerre I, Pinton F, Nabbout R et al (2003) Infantile spasms with basal ganglia MRI hypersignal may reveal mitochondrial disorder due to T8993G mt DNA mutation. Neuropediatrics 34: 265-269
47. Di Bella D, Lazzaro F, Brusco A et al (2010) Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary Ataxia SCA28. Nat Genet 42:313-321
48. Di Donato S (2000) Disorders related to mitochondrial membranes: pathology of the respiratory chain and neurodegeneration. J Inherit Metab Dis 23:247-263
49. Di Donato S (2009) Multisystem manifestations of mitochondrial disorders. J Neurol 256:693-710
50. Di Donato S, Taroni F (2008) Disorders of lipid metabolism. In: Rosemberg R, DiMauro S, Paulson et al. (eds) The molecular and genetic basis of neurological and psychiatric disease, 4th edn. Wolter Kluvers/Lippincot Williams & Wilkins, Philadelphia, pp 610-623
51. Di Mauro S, Schon E (2008) Mitochondrial disorders in the nervous system. Ann Rev Neurosci 31:91-123
52. Di Mauro S, Hirano M, Kaufmann P et al (2002) Clinical features and genetics of myoclonic epilepsy with ragged red fibers. Adv Neurol 89:217-229
53. Di Prospero NA, Baker A, Jeffries N et al (2007) Neurological effects of high-dose idebenone in patients with Friedreich’s Ataxia: a randomised, placebo-controlled trial. Lancet Neurol 6: 878-886
54. Duby G, Foury F, Ramazzotti A et al (2000) A non-essential function for yeast frataxin in iron-sulfur cluster assembly. Hum Mol Genet 11:2635-2643
55. Dürr A, Cossee M, Agid Y et al (1996) Clinical and genetic abnormalities in patients with Friedreich’s Ataxia. N Engl J Med 335:1169-1175
56. Edener U, Wollner J, Hehr U et al (2010) Early onset and slow progression of SCA28, a rare dominant Ataxia in a large four-generation family with a novel AFG3L2 mutation. Eur J Hum Genet 18:965-968
57. Engelsen BA, Tzoulis C, Karlsen B et al (2008) POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection. Brain 131:818-828
58. Fadic R, Russell JA, Vedanarayanan VV et al (1997) Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease. Neurology 49:239-245
59. Fahey MC, Cremer PD, Aw ST et al (2008) Vestibular, saccadic and fixation abnormalities in genetically confirmed Friedreich Ataxia. Brain 131(Pt 4):1035-1045
60. Fan W (2008) A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations. Science 319:958-962
61. Fayssoil A (2009) Heart diseases in mitochondrial encephalomyopathy, lactic acidosis, and stroke syndrome. Congest Heart Fail 15:284-287
62. Finocchiaro G, Baio G, Micossi P et al (1988) Glucose metabolism alterations in Friedreich’s Ataxia. Neurology 38:1292-1296
63. Finsterer J (2008) Leigh and Leigh-like syndrome in children and adults. Pediatr Neurol 39:223-35
64. Fortuna F, Barboni P, Liguori R et al (2009) Visual system involvement in patients with Friedreich’s Ataxia. Brain 132:116-123
65. Frezza C, Cipolat S, de Brito OM et al (2006) OPA1 controls apoptotic christae remodelling independently from mitochondrial fusion. Cell 126:177-189
66. Fukuhara N (1991) MERRF: a clinicopathological study - relationships between myoclonus epilepsies and mitochondrial myopathies. Rev Neurol (Paris) 147:476-79
67. Fukuhara N (2008) Fukuhara disease. Brain Nerve 60:53-58
68. Gellera C, Pareyson D, Castellotti B et al (1997) Very late onset Friedreich’s Ataxia without genetically confirmed Friedreich Ataxia. Brain 131:1035-1045
69. Gellera C, Castellotti B, Mariotti C et al (2007) Frataxin gene point mutations in Italian Friedreich Ataxia patients. Neurogenetics 8:289-299
70. Geoffroy G, Barbeau A, Breton A et al (1976) Clinical description and roentgenologic evaluation of patients with Friedreich’s Ataxia. Can J Neurol Sci 3:279-286
71. Gillis JC, Benefield P, McTavish D (1994) Idebenone A review of its pharmacodynamic and therapeutic use in age-related cognitive disorders. Drugs Aging 5(2):133-152
72. Gottesfeld JM (2007) Small molecules affecting transcription in Friedreich Ataxia. Pharmacol Ther 116:236-248
73. Hakonen AH, Heiskanen S, Juvonen V et al (2005) Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive Ataxia with ancient European origin. Am J Hum Genet 77:430-441
74. Hakonen AH, Isohanni P, Paetau A et al (2007) Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain 130(Pt 11):3032-3040
75. Hakonen AH, Goffart S, Marjavaara S et al (2008) Infantile-onset spinocerebellar Ataxia and mitochondrial recessive Ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Hum Mol Genet 17(23):3822-3835
76. Harding AE (1981) Friedreich’s Ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104:589-620
77. Harding AE (1983) Classification of the hereditary Ataxias and paraplegias. Lancet 1:1151-1155
78. Harding AE (1993) Clinical features and classification of inherited Ataxias. Adv Neurol 61:1-14
79. Hellier KD, Hatchwell E, Duncombe AS et al (2001) X-linked sideroblastic anaemia with Ataxia: another mitochondrial disease? J Neurol Neurosurg Psychiatry 70:65-69
80. Hirano M, Pavlakis S (1994) Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol 9:4-13
81. Holt I, Harding A, Petty R, Morgan-Hughes J (1990) A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 46:428-433
82. Huang C, Kuo H, Chu C et al (2002) Clinical phenotype, prognosis and mitochondrial DNA mutation load in mitochondrial encephalomyopathies. J Biomed Sci 9:527-533
83. Hudson G, Deschauer M, Busse K et al (2005) Sensory ataxic neuropathy due to a novel C10Orf2 mutation with probable germline mosaicism. Neurology 64:371-373
84. Huizing M (1998) Mitochondrial transmembrane carriers in mitochondriocytopathies. Work of Thesis, Kattholieke Universiteit Nijmegen, pp 8-34
85. Hutchin TP, Cortopassi G (2000) Mitochondrial defects and hearing loss. Cell Mol Life Sci 57:1927-1937
86. Iizuka T, Sakai F, Kan S et al (2003) Slowly progressive spread of the stroke-like lesions in MELAS. Neurology 61:1238-1244
87. Ishikawa Y, Goto Y, Ishikawa Y et al (2000) Progression in a case of Kearns-Sayre syndrome. J Child Neurol 11:750-755
88. Isnard R, Kalotka H, Durr A et al (1997) Correlation between left ventricular hypertrophy and GAA trinucleotide repeat length in Friedreich’s Ataxia. Circulation 95:2247-2249
89. Ito S, Shirai W, Asahina M et al (2008) Clinical and brain MR imaging features focusing on the brain stem and cerebellum in patients with myoclonic epilepsy with ragged-red fibers due to mitochondrial A8344G mutation. AJNR Am J Neuroradiol 29:392-395
90. Jacobs H, Holt I et al (2000) The np 3243 MELAS mutation: damned if you aminoacylate, damned if you don’t. Hum Mol Genet 9:463-465
91. Jaksch M, Klopstock T, Kurlemann G et al (1998) Progressive myoclonus epilepsy and mitochondrial myopathy associated with mutations in the tRNA(Ser(UCN)) gene. Ann Neurol 44: 635-640
92. Kaguni LS (2004) DNA polymerase gamma, the mitochondrial replicase. Annu Rev Biochem 73:293-320
93. Kaukonen J, Juselius J, Tiranti V et al (2000) Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289:782-785
94. Kearney M, Orrell RW et al. (2009) Antioxidants and other pharmacological treatments for Friedreich Ataxia. Cochrane Database Syst Rev CD007791
95. Kearns T, Sayrne G et al (1958) Retinitis pigmentosa, external ophthalmophegia, and complete heart block: unusual syndrome with histologic study in one of two cases. AMA Arch Ophthalmol 60:280-289
96. Kipps A, Alexander M, Colan SD et al (2009) The longitudinal course of cardiomyopathy in Friedreich’s Ataxia during childhood. Pediatr Cardiol 30:306-310
97. Klockgether T, Zühlke C, Schulz JB et al (1996) Friedreich’s Ataxia with retained tendon reflexes: molecular genetics, clinical neurophysiology, and magnetic resonance imaging. Neurology 46:118-121
98. Kobayashi Y, Momoi MY, Tominaga K et al (1991) Respiration-deficient cells are caused by a single point mutation in the mitochondrial tRNA-Leu (UUR) gene in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Am J Hum Genet 49:590-599
99. Koehler C, Jarosch E, Tokatlidis K et al (1998) Import of mitochondrial carriers mediated by essential proteins of the inner membrane space. Science 279:369-373
100. Koeppen AH (1998) The hereditary Ataxias. J Neuropathol Exp Neurol 57:531-543
101. Kolb S, Costello F, Lee AG et al (2003) Distinguishing ischemic stroke from the stroke-like lesions of MELAS using apparent diffusion coefficient mapping. J Neurol Sci 216:11-15
102. Labuda M, Labuda D, Miranda C et al (2000) Unique origin and specific ethnic distribution of the Friedreich Ataxia GAA expansion. Neurology 54:2322-2324
103. Lagier-Tourenne C, Tazir M, Lopez LC et al (2008) ADCK3, an ancestral kinase, is mutated in a form of recessive Ataxia associated with coenzyme Q10 deficiency. Am J Hum Genet 82:661-672
104. Lamantea E, Tiranti V, Bordoni A et al (2002) Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann Neurol 52:211-219
105. Lamarche JB, Cote M, Lemieux B (1980) The cardiomyopathy of Friedreich’s Ataxia morphological observations in 3 cases. Can J Neurol Sci 7:389-396
106. Lamarche JB, Lemieux B, Lieu HB (1984) The neuropathology of "typical" Friedreich’s Ataxia in Quebec. Can J Neurol Sci 11:592-600
107. Lamperti C, Naini A, Hirano M et al (2003) Cerebellar Ataxia and coenzyme Q10 deficiency. Neurology 60(7):1206-1208
108. Langer T (2000) AAA proteases: cellular machines for degrading membrane proteins. Trends Biochem Sci 25:247-251
109. Llorens JV, Navarro JA, Martinez-Sebastian MJ et al (2007) Causative role of oxidative stress in a Drosophila model of Friedreich Ataxia. FASEB J 21:333-344
110. Lonnqvist T, Paetau A, Nikali K et al (1998) Infantile onset spinocerebellar Ataxia with sensory neuropathy (IOSCA): neuropathological features. J Neurol Sci 161:57-65
111. Lonnqvist T, Paetau A, Valanne L et al (2009) Recessive twinkle mutations cause severe epileptic encephalopathy. Brain 132:1553-1562
112. Lynch DR, Perlman SL, Meier T (2010) A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich Ataxia. Arch Neurol 67:941-947
113. Manto M (2010) Cerebellar disorders. Cambridge University Press, Cambridge, UK
114. Mariotti C, Solari A, Torta D et al (2003) Idebenone treatment in Friedreich patients: one-yearlong randomized placebo-controlled trial. Neurology 60:1676-1679
115. Mariotti C, Brusco A, Di Bella D et al (2008) Spinocerebellar Ataxia type 28: a novel autosomal dominant cerebellar Ataxia characterized by slow progression and ophthalmoparesis. Cerebellum 7:184-188
116. Marmolino D, Acquaviva F (2009) Friedreich’s Ataxia: from the (GAA)n repeat mediated silencing to new promising molecules for therapy. Cerebellum 8:245-259
117. Marmolino D, Acquaviva F, Pinelli M et al (2009) PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich’s Ataxia therapy. Cerebellum 8:98-103
118. Martelli A, Wattenhofer-Donze M, Schmucker S, Bouvet S, Reutenauer L, Puccio H (2007) Frataxin is extramitochondrial Fe-S cluster proteins in mammalian tissues. Hum Mol Genet 16:2651-2658
119. Martinelli P, La Mattina V, Bernacchia A et al (2009) Genetic interaction between the m-AAA protease isoenzymes reveals novel roles in cerebellar degeneration. Hum Mol Genet 18: 2001-2013
120. Mascalchi M, Salvi F, Piacentini S et al (1994) Friedreich’s Ataxia: MR findings involving the cervical portion of the spinal cord. AJR Am J Roentgenol 163:187-191
121. Mehrazin M, Shanske S, Kaufmann P et al (2009) Longitudinal changes of mtDNA A3243G mutation load and level of functioning in MELAS. Am J Med Genet 149:584-587
122. Milone M, Brunetti-Pierri N, Tang LY et al (2008) Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations. Neuromuscul Disord 18:626-632
123. Mollet J, Delahodde A, Serre V et al (2008) CABC1 gene mutations cause ubiquinone deficiency with cerebellar Ataxia and seizures. Am J Hum Genet 82:623-630
124. Montermini L, Richter A, Morgan K et al (1997) Phenotypic variability in Friedreich Ataxia: role of the associated GAA triplet repeat expansion. Ann Neurol 41:675-682
125. Montero R, Pineda M, Aracil A et al (2007) Clinical, biochemical and molecular aspects of cerebellar Ataxia and coenzyme Q10 deficiency. Cerebellum 6:118-122
126. Moraes CT, Sciacco M, Ricci E et al (1995) Phenotype-genotype correlations in skeletal muscle of patients with mtDNA deletions. Muscle Nerve 3:150-S153
127. Moreno-Loshuertos R, Acín-Perez R, Fernandez-Silva P et al (2006) Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants. Nat Genet 38:1261-1268
128. Morgello S, Peterson H, Kahn L et al (1988) Menkes kinky hair disease with “ragged red” fibers. Dev Med Child Neurol 30:812-816
129. Nakamura M, Nakano S, Goto Y et al (1995) A novel point mutation in the tRNAser(UCN) gene detected in a family with MERRF/MELAS overlap syndrome. Biochem Biophys Res Commun 14:86-93
130. Naviaux RK, Nguyen KV et al (2004) POLG mutations associated with Alpers’ syndrome. Neurology 60:1206-1208
131. Nikali K, Suomalainen A, Saharinen J et al (2005) Infantile onset spinocerebellar Ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky. Hum Mol Genet 14: 2981-2990
132. Ohama E, Ohara S, Ikuta F et al (1987) Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol 74:226-233
133. Ohshima K, Montermini L, Wells RD et al (1998) Inhibitory effects of expanded GAA.TTC triplet repeats from intron I of the Friedreich Ataxia gene on transcription and replication in vivo. J Biol Chem 273:14588-14595
134. Oldfors A, Holme E, Tulinius M et al (1995) Tissue distribution and disease manifestations of the tRNA(Lys) A- > G(8344) mitochondrial DNA mutation in a case of myoclonus epilepsy and ragged red fibres. Acta Neuropathol 90:328-333
135. Ota Y, Miyake Y, Awaya S et al (1994) Early retinal involvement in mitochondrial myopathy with mitochondrial DNA deletion. Retina 14:270-276
136. Palau F, De Michele G, Vilchez JJ et al (1995) Early-onset Ataxia with cardiomyopathy and retained tendon reflexes maps to the Friedreich’s Ataxia locus on chromosome 9q. Ann Neurol 37:359-362
137. Palmieri L, Lasorsa FM, Vozza A et al (2000) Identification and functions of new transporters in yeast mitochondria. Biochim Biophys Acta 1459(2-3):363-369
138. Pandolfo M (2006) Friedreich Ataxia: Detection of GAA repeat expansions and frataxin point mutations. Methods Mol Med 126:197-216
139. Pandolfo M (2008a) Drug insight: antioxidant therapy in inherited Ataxias. Nat Clin Pract Neurol 4:86-96
140. Pandolfo M (2008b) Friedreich Ataxia. Arch Neurol 65:1296-1303
141. Pandolfo M, Pastore A (2009) The pathogenesis of Friedreich Ataxia and the structure and function of frataxin. J Neurol 1:9-17
142. Petruzzella V, Zoccolella S, Amati A et al (2004) Cerebellar Ataxia as atypical manifestation of the 3243A > G MELAS mutation. Clin Genet 65:64-65
143. Pineda M, Montero R, Aracil A et al (2010) Coenzyme Q(10)-responsive Ataxia: 2-year-treatment follow-up. Mov Disord 25:1262-1268
144. Piruat J, Lopez-Barneo J (2005) Oxygen tension regulates mitochondrial DNA-encoded complex I gene expression. J Biol Chem 52:42676-42684
145. Poulton J, Deadman M, Gardiner R (1989) Duplications of mitochondrial DNA in mitochondrial myopathy. Lancet 1:236-240
146. Poyton R, McEwen JE (1996) Crosstalk between nuclear and mitochondrial genomes. Annu Rev Biochem 65:563-607
147. Puccio H (2009) Multicellular models of Friedreich Ataxia. J Neurol 1:18-24
148. Puccio H, Simon D, Cossee M et al (2001) Mouse models for Friedreich Ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 27:181-186
149. Quinzii CM, Hirano M (2010) Coenzyme Q and mitochondrial disease. Dev Disabil Res Rev 16:183-188
150. Quinzii CM, Lopez LC, Naini A et al (2008) Human CoQ10 deficiencies. Biofactors 32: 113-118
151. Ramelli G, Gallati S, Weis J et al (2006) Point mutation tRNA(Ser(UCN)) in a child with hearing loss and myoclonus epilepsy. J Child Neurol 21:253-255
152. Ricquier D, Bouillard F (2000) Mitochondrial uncoupling proteins: from mitochondria to the regulation of energy balance. J Physiol 529:3-10
153. Rizzuto R, Bernardi P, Pozzan T (2000) Mitochondria as all-round players of the calcium game. J Physiol 529:37-47
154. Robain O, Aubourg P, Routon M (1988) Menkes disease: a Golgi and electron microscopic study of the cerebellar cortex. Clin Neuropathol 7:47-52
155. Rojo A, Campos Y, Sanchez J et al (2006) NARP-MILS syndrome caused by 8993 T > G mitochondrial DNA mutation: a clinical, genetic and neuropathological study. Acta Neuropathol 111:610-616
156. Rotig A, de Lonlay P, Chretien D et al (1997) Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich Ataxia. Nat Genet 17:215-217
157. Sandi C, Pinto RM, Al-Mahdawi S et al (2011) Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich Ataxia mouse model. Neurobiol Dis 42(3):496-505
158. Sano M, Ishii K, Momose Y et al (1995) Cerebral metabolism of oxygen and glucose in a patient with MELAS syndrome. Acta Neurol Scand 92:497-502
159. Santorelli F, Shanske S, Macaya A et al (1993) The mutation at nt 8993 of mitochondrial DNAis a common cause of Leigh’s syndrome. Ann Neurol 34:827-34
160. Santorelli F, Tanji K, Shanske S et al (1997) Heterogeneous clinical presentation of the mtDNA NARP/T8993G mutation. Neurology 49:270-273
161. Santos R, Lefevre S, Sliwa D et al (2010) Friedreich Ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities. Antioxid Redox Signal 13(5):651-90
162. Saraste M (1999) Oxidative phosphorylation fin siecle. Science 283:1488-1492
163. Sasarman F, Antonicka H, Shoubridge E (2008) The A3243G tRNALeu(UUR) MELAS mutation causes amino acid misincorporation and a combined respiratory chain assembly defect partially suppressed by overexpression of EFTu and EFG2. Hum Mol Genet 17:3697-3707
164. Schatz G, Dobberstein B (1996) Common principles of protein translocation across membranes. Science 271:1519-26
165. Schmucker S, Puccio H (2010) Understanding the molecular mechanisms of Friedreich’s Ataxia to develop therapeutic approaches. Hum Mol Genet 19:R103-R110
166. Schmucker S, Martelli A, Colin F et al (2011) Mammalian frataxin: an essential function for cellular viability through an interaction with a preformed ISCU/NFS1/ISD11 iron-sulfur assembly complex. PLoS ONE 6:e16199
167. Schols L, Amoiridis G, Przuntek H et al (1997) Friedreich’s Ataxia. Revision phenotype according molecular genetics. Brain 120:2131-2140
168. Schulz JB, Boesch S, Burk K et al (2009) Diagnosis and treatment of Friedreich Ataxia: a European perspective. Nat Rev Neurol 5:222-234
169. Sciacco M, Prelle A, D’Adda E et al (2003) Familial mtDNA T8993C transition causing both the NARP and the MILS phenotype in the same generation. A morphological, genetic and spectroscopic study. J Neurol 250:1498-1500
170. Seznec H, Simon D, Monassier L et al (2004) Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich Ataxia. Hum Mol Genet 13(10):1017-1024
171. Seznec H, Simon D, Bouton C et al (2005) Friedreich Ataxia: the oxidative stress paradox. Hum Mol Genet 14:463-474
172. Shanske S, Coku J, Lu J et al (2008) The G13513A mutation in the ND5 gene of mitochondrial DNA as a common cause of MELAS or Leigh syndrome: evidence from 12 cases. Arch Neurol 65:368-372
173. Shoffner J, Lott M, Lezza A et al (1990) Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA-lys mutation. Cell 61:931-937
174. Silvestri G, Moraes C, Shanske S et al (1992) A new mtDNA mutation in the tRNA(Lys) gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet 51:1213-1217
175. Simaan EM, Mikati MA, Touma EH, Rotig A (1999) Unusual presentation of Kearns-Sayre syndrome in early childhood. Pediatr Neurol 21(5):830-831
176. Smeitink J, Zeviani M, Turnbull D et al (2006) Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab 3:9-13
177. So N, Berkovic S, Andermann F et al (1989) Myoclonus epilepsy and ragged-red fibres (MERRF). 2 Electrophysiological studies and comparison with other progressive myoclonus epilepsies. Brain 112:1261-1276
178. Sohn YS, Breuer W, Munnich A et al (2008) Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications. Blood 111:1690-1699
179. Sparaco M, Bonilla E, DiMauro S et al (1993) Neuropathy of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 52:1-10
180. Spelbrink JN, Li FY, Tiranti V et al (2001) Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 28:223-231
181. Stehling O, Elsasser HP, Bruckel B et al (2004) Iron-sulfur protein maturation in human cells: evidence for a function of frataxin. Hum Mol Genet 13:3007-3015
182. Stepien G, Torroni A, Chung A et al (1992) Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation. J Biol Chem 267:14592-14597
183. Stewart JD, Horvath R, Baruffini E et al (2010) Polymerase gamma gene POLG determines the risk of sodium valproate-induced liver toxicity. Hepatology 52:1791-1796
184. Stryer L (1988) Biochemistry, 3rd edn. Freeman WH and company, New York, pp 373-379
185. Tanahashi C, Nakayama A, Yoshida M et al (2000) MELAS with the mitochondrial DNA 3243 point mutation: a neuropathological study. Acta Neuropathol 99:31-38
186. Tanji K, Vu T, Schon E et al (1999) Kearns-Sayre syndrome: unusual pattern of expression of subunits of the respiratory chain in the cerebellar system. Ann Neurol 45:377-383
187. Tatsuta T, Langer T (2008) Quality control of mitochondria: protection against neurodegeneration and ageing. EMBO J 27:306-314
188. Tatuch Y, Christodoulou J, Feigenbaum A et al (1992) Heteroplasmic mtDNA mutation (T-G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 50:852-858
189. Tay S, Nordli D, Bonilla E et al (2006) Aortic rupture in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes. Arch Neurol 63:281-283
190. Taylor R, Turnbull D (2005) Mitochondrial DNA mutations in human disease. Nat Rev Genet 6:389-402
191. Testai F, Gorelick P (2010) Inherited metabolic disorders and stroke part 1: Fabry disease and mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes. Arch Neurol 67:19-24
192. Tiranti V, Chariot P, Carella F et al (1995) Maternally inherited hearing loss, Ataxia and myoclonus associated with a novel point mutation in mitochondrial tRNASer(UCN) gene. Hum Mol Genet 4:1421-1427
193. Tsai CL, Barondeau DP (2010) Human frataxin is an allosteric switch that activates the Fe-S cluster biosynthetic complex. Biochemistry 49:9132-9139
194. Tzoulis C, Bindoff LA (2009) The syndrome of mitochondrial spinocerebellar Ataxias and epilepsy caused by POLG mutations. Adv Clin Neurosci Rehabil 9:13-16
195. Tzoulis C, Engelsen BA, Telstad W et al (2006) The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 129:1685-1692
196. Uziel G, Moroni I, Lamantea E et al (1997) Mitochondrial disease associated with the T8993G mutation of the mitochondrial ATPase 6 gene: a clinical, biochemical, and molecular study in six families. J Neurol Neurosurg Psychiatry 63:16-22
197. Van Goethem G, Dermaut B, Lofgren A et al (2001) Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 28: 211-212
198. Van Goethem G, Martin JJ, Dermaut B et al (2003a) Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 13:133-142
199. Van Goethem G, Mercelis R, Lofgren A et al (2003b) Patient homozygous for a recessive POLG mutation presents with features of MERRF. Neurology 61:1811-1813
200. Van Goethem G, Luoma P, Rantamaki M et al (2004) POLG mutations in neurodegenerative disorders with Ataxia but no muscle involvement. Neurology 63:1251-1257
201. Wallace D (2007) Why do we still have a maternally inherited mitochondrial DNA? Insights from evolutionary medicine. Annu Rev Biochem 76:781-821
202. Wallace D (2010) Bioenergetics, the origins of complexity, and the ascent of man. Proc Natl Acad Sci USA 107:8947-8953
203. Wallace D, Zheng X, Lott M et al (1988) Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 55:601-610
204. Wang T, Craig EA (2008) Binding of yeast frataxin to the scaffold for Fe-S cluster biogenesis, Isu. J Biol Chem 283:12674-12679
205. Watanabe Y, Hashikawa K, Moriwaki H et al (1998) SPECT findings in mitochondrial encephalo-myopathy. J Nucl Med 39:961
206. Wells RD (2008) DNA triplexes and Friedreich Ataxia. FASEB J 22:1625-1634
207. Winterthun S, Ferrari G, He L et al (2005) Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology 64:1204-1208
208. Wong A, Yang J, Cavadini P et al (1999) The Friedreich’s Ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet 8:425-430
209. Wong LJ, Naviaux RK, Brunetti-Pierri N et al (2008) Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat 29:E150-E172
210. Wullner U, Klockgether T, Petersen D (1993) Magnetic resonance imaging in hereditary and idiopathic Ataxia. Neurology 43:318-325
211. Yakubovskaya E, Chen Z, Carrodeguas JA et al (2006) Functional human mitochondrial DNA polymerase gamma forms a heterotrimer. J Biol Chem 281:374-382
212. Youle R, Karbowski M (2005) Mitochondrial fission in apoptosis. Nat Rev Mol Cell Biol 6: 657-663
213. Zeviani M, Di Donato S (2004) Mitochondrial disorders. Brain 127:2153-2172
214. Zouari M, Feki M, Ben Hamida C et al (1998) Electrophysiology and nerve biopsy: comparative study in Friedreich’s Ataxia and Friedreich’s Ataxia phenotype with vitamin E deficiency. Neuromuscul Disord 8:416-425
215. Zsurka G, Baron M, Stewart JD et al (2008) Clonally expanded mitochondrial DNA mutations in epileptic individuals with mutated DNA polymerase gamma. J Neuropathol Exp Neurol 67:857-866